Cleantech investing surges 73 percent in Q2 after gloomy Q1
Investment in the cleantech sector leaped 73 percent to $572 million in the second quarter. Financing was distributed across 48 rounds — a full 100 percent increase from the previous quarter, according to new analysis from Ernst & Young based on Dow Jones Venture Source data. These stats defy the basement levels of investment in the sector earlier this year.
That being said, the figures are still down from where they were a year ago. The… Continue Reading
Biotech venture funding takes a hit, but devices are hot
Venture-capital financing may be at a six-year high, but the picture in life sciences is a mixed one. After a blowout first quarter, second-quarter fundings in biotechnology actually dropped 19 percent, to $1.1 billion, compared to the same period last year, according to data from Dow Jones VentureOne and Ernst & Young. Medical-device investments, however, were on a tear, with VCs funneling more than $1 billion into the sector during the quarter — the highest… Continue Reading
VCs open pockets for health, but neglect IT
Venture capitalists pumped eight percent more into companies during the first quarter, but all the action came in healthcare.
Venture capitalists gave 16 percent less to companies in the IT industry, however — they invested less money into software, semiconductors and Internet infrastructure companies. Web 2.0 companies, however, appear to have drawn more money than ever. See table below. Web 2.0 companies are part of the “Information services” category, which saw $722 million, up from $659… Continue Reading
Heathcare venture funding surges in first quarter
Biotechnology and medical-device venture investment soared in the first quarter as funding for information technology and other sectors declined, according to data compiled by Ernst & Young and Dow Jones VentureOne.
Overall venture funding for U.S. companies rose 8% in the quarter, compared to the same period last year. Biotech firms pulled in a record $1.8 billion, more than double what the industry raised a year earlier. Funding for medical-device companies rose 55% to $953 million…. Continue Reading